Arsenic is an important environmental carcinogen that affects millions of people worldwide through contaminated water supplies. For decades, arsenic was considered a nongenotoxic carcinogen. Using the highly sensitive A L mutation assay, we previously showed that arsenic is, indeed, a potent gene and chromosomal mutagen and that its effects are mediated through the induction of reactive oxygen species. However, the origin of these radicals and the pathways involved are not known. Here we show that mitochondrial damage plays a crucial role in arsenic mutagenicity. Treatment of enucleated cells with arsenic followed by rescue fusion with karyoplasts from controls resulted in significant mutant induction. In contrast, treatment of mitochondrial DNA-depleted (R 0 ) cells produced few or no mutations. Mitochondrial damage can lead to the release of superoxide anions, which then react with nitric oxide to produce the highly reactive peroxynitrites. The mutagenic damage was dampened by the nitric oxide synthase inhibitor, N G -methyl-L-arginine. These data illustrate that mitochondria are a primary target in arsenic-induced genotoxic response and that a better understanding of the mutagenic/carcinogenic mechanism of arsenic should provide a basis for better interventional approach in both treatment and prevention of arsenic-induced cancer. (Cancer Res 2005; 65(8): 3236-42) 
Introduction
Inorganic arsenic is naturally occurring and ubiquitously present in the environment. Contamination of drinking water by arsenic, either by natural means or through industrial pollution, represents the major route of human exposure (1, 2) . It is a serious environmental problem worldwide because of the large number of contaminated sites that have been identified and the hundreds of millions of people at risk, particularly in developing countries, such as West Bengal in India and Bangladesh (3, 4) . Although the water supplies in the United States are generally low in arsenic, there have been reports of arsenic contamination of ground water in the Southwest with levels in the hundreds and, in few cases, >1,000 Ag/L (1). In the United States, arsenic contamination of the environment is mainly through the use of chromated copper arsenate-preserved timbers in the construction industry (5) . Leaching of arsenic and other preservative components from wood used in aquatic and residential situations poses serious threat to the environment with some 140 million pounds of chromated copper arsenate solution being used annually.
Epidemiologic data have shown that chronic exposure of humans to inorganic arsenical compounds is associated with liver injury, peripheral neuropathy, and an increased incidence of cancer of the lung, skin, bladder, and liver (6, 7) . However, the mechanism(s) underlying its carcinogenicity remains poorly understood. For decades, arsenic has been considered by many to be a nongenotoxic carcinogen. Although it has been shown to induce chromosomal aberrations and inhibit DNA repair, it is only weakly active or, more often, completely inactive in bacterial and mammalian cell mutation assays (8) (9) (10) . Using the A L humanhamster hybrid cell assay, we showed that this could be a result of the poor recovery of multilocus mutations that are prevalently induced by arsenic so that arsenic is, in fact, a potent mutagen (11, 12) . We further showed that hydroxyl radicals, generated through a superoxide-mediated process involving hydrogen peroxide, play an important role in mediating the genotoxic effects of arsenic (13) . These findings are consistent with the reports stipulating the functional role of oxidants in mediating the biological effects of arsenite by linking glutathione content (14) , heme oxygenase (15, 16) , oxidative DNA damage (12, 17) , and metallothionine (18) to the end points being examined. However, the origin of these oxyradical species and the pathways involved in the generation of other secondary radical species are not known.
Synthesis of ATP in mitochondria requires oxidative metabolism and the consumption of oxygen, which results in the production of various reactive oxygen species including hydroxyl radicals and superoxide anions as by-products. It is likely that arsenic-induced mitochondrial membrane damage results in the leakage of superoxide anions into the cytosol of cells, a possibility that is consistent with our previous observation based on electron spin resonance (ESR) spin trap studies (13) . There is evidence that arsenic up-regulates intracellular nitric oxide concentration in mammalian cells (19, 20) . A possible consequence of mitochondrial damage is, therefore, the secondary production of peroxynitrites, a strong oxidant formed by the diffusion-controlled reaction of superoxides and nitric oxide (21) . In this regard, there is recent evidence that arsenic induces peroxynitrite production in bovine endothelial cells and may exacerbate the inflammatory process typical of atherosclerosis (22) . Whereas arsenic has been shown to alter mitochondrial membrane potential and induce apoptosis in various human cancer cells (23, 24) , the role of mitochondria as a genotoxic target of arsenic has yet to be established. Using enucleation and fusion techniques and the human-hamster hybrid (A L ) cells, we show here that mitochondria are a direct target of arsenic-induced genotoxicity in mammalian cells and that peroxynitrite anions are an important mediator in the process.
Materials and Methods
Cell culture. The A L hybrid cells, which contain a standard set of CHO-K1 chromosomes and a single copy of human chromosome 11, were used. Chromosome 11 encodes cellular surface markers that render A L cells sensitive to killing by specific monoclonal antibodies in the presence of rabbit serum complement (HPR, Inc., Denver, PA). Antibody E7.1 specific to the CD59 antigen was produced from hybridoma culture as described (25, 26) . Cells were maintained in Ham's F-12 medium, supplemented with 8% heat-inactivated fetal bovine serum, 25 Ag/mL gentamicin, and 2Â normal glycine (2 Â 10 À4 mol/L), at 37jC in a humidified 5% CO 2 incubator and passaged as described (11, 13, 27) . Chemical treatment. Stock solution (1 mg/mL) of sodium arsenite (Sigma Chemical, St. Louis, MO) was prepared and used as described (11, 12) . Working concentrations were prepared by diluting the stock with complete F-12 medium. Enucleated cytoplasts and mitochondrial DNA (mtDNA)-deficient cells were treated with graded doses of arsenite for various periods of time as indicated. After treatment, cells were washed twice with plain F-12 medium and processed for the various end points as described. In experiments involving the nitric oxide synthase inhibitor, both the active N G -methyl-L-arginine (L-NMMA) and the inactive enantiomer N G -methyl-Darginine (D-NMMA; Molecular Probes, Inc., Eugene, OR), dissolved in F-12 medium and filter sterilized, were added to the cultures 1 hour before arsenic treatment and remained in the medium throughout the treatment period. Enucleation of A L cells. Exponentially growing A L cells (f2 Â 10 5 cells per dish) grown in either 35-mm-diameter tissue culture plastic dishes or 35 mm glass bottom microwell dishes (DTC3 dishes, BiopTechs, Butler, PA) were enucleated as described (28, 29) . Briefly, cells were treated with cytochalasin B (1 Ag/mL) for 60 minutes and the dishes containing the cells were centrifuged upside down inside a 250 mL Sorvall centrifuge bottle (Nalge-Nunc International, Binghamton, NY) using a GSA rotor at 6,700 rpm at 37jC for 20 minutes. After centrifugation, the cultures were washed thrice with complete medium to remove excess cytochalasin B. The enucleated cells were then incubated at 37jC for 30 minutes to recover before treatment with arsenite. The efficiency of enucleation was evaluated by the absence of nuclear staining with a 50 nmol/L solution of Hoechst 33342 (Polysciences, Warington, PA) for 20 minutes. The cytoplasts were then treated with arsenite for a period of 3 to 4 hours as described above.
Preparation of karyoplast from A L cells. The nuclei that were centrifuged out of the A L cells, containing a small amount of cytoplasm (<10% v/v of controls), would remain at the bottom of the centrifuge tubes along with some whole cells that escaped enucleation. Karyoplasts were collected and pelleted by centrifugation at 1,500 rpm for 5 minutes at 37jC. After washing with medium twice to remove remnants of cytochalasin B, the karyoplasts were resuspended in complete F-12 medium until fusion with cytoplasts. The percentage of whole cells in the karyoplast preparation was evaluated by staining with Hoechst dye as described above. Karyoplast preparations with <5% whole cells were used for cytoplast fusion. Viability of karyoplasts obtained was >95% as determined by trypan blue staining.
Fusion of cytoplasts with karyoplasts. Control or arsenite-treated cytoplasts grown in 35-mm-diameter dishes (f2 Â 10 5 cells per dish) were washed twice with F-12 medium and fused with karyoplasts in a ratio of 3:1 using 50% polyethylene glycol (PEG-1450, American Type Culture Collection, Manassas, VA) as described (29, 30) . Briefly, the cytoplastkaryoplast mixture was incubated in a 5% CO 2 incubator at 37jC for 2 hours before fusion. To initiate the fusion, medium was aspirated, and 1 mL of prewarmed, sterile 50% PEG containing 10% DMSO (pH 7.3) was added drop-wise over 1 minute. Immediately, complete F-12 medium was added and the fusion mixture was returned to the incubator. After 4 to 5 hours of incubation, the fusion cells were replenished with fresh F-12 medium containing 50 Ag/mL uridine. This step was necessary to provide cells with diminished respiratory chain function an additional source of pyrimidine for better recovery (31) . Fusion cells were incubated for 5 to 6 days before being trypsinized and expanded for clonogenic survival and mutagenesis assay as described below.
Determination of reactive oxygen species formation in arsenitetreated cytoplasts. To quantify the level of reactive oxygen species in arsenic-treated live cells, cytoplasts and, in untreated controls, exponentially growing A L cells and freshly enucleated cytoplasts (2 Â 10 5 cells) grown on 35 mm glass bottom microwell dishes (DTC3 dishes, BiopTechs), were pretreated for 40 minutes at 37jC with 1 Amol/L fluorescent probe, 5V,6V -chloromethyl-2V,7Vdichlorodihydro-fluorescein diacetate (CM-H 2 DCFDA, Molecular Probes; refs. 13, 32) . Graded doses of arsenite, with or without the radical scavenger DMSO (0.1%), were then added to the cultures. Cultures were examined using a confocal microscope and a semiquantitative estimation of the reactive oxygen species-associated fluorescent signal, expressed as percent control, was obtained using the composite images generated by Adobe Photoshop (Adobe Systems, Inc., San Jose, CA). A total of 50 to 60 individual cells per experiment were selected randomly and the fluorescent images quantified. On average, over 300 cells were measured per treatment group as described (13) .
Generation of mitochondrial DNA-deficient R 0 A L cells. Exponentially growing A L cells grown in 100-mm-diameter tissue culture dishes were treated with freshly prepared chemotherapeutic drug ditercalinium (gift sample from Dr. Robert Schultz, National Cancer Institute, NIH, Bethesda, MD) in F-12 medium at a dose of 1.5 Ag/mL for 3 to 4 months in the presence of uridine (50 Ag/mL) as described (33, 34) . During this time period, colonies of drug-resistant cells were cloned and continued to be passaged in drugcontaining medium. Fresh medium was replenished every 3 to 4 days. Periodically, expression of mtDNA in ditercalinium-treated clonal isolates was determined by PCR amplification of genomic DNA using the peptidyl transferase encoding region of the mitochondrial 16S rRNA gene as primer (33) . When the mtDNA was found to be >95% depleted in the population, these U 0 cells were rinsed twice with HBSS and used in the mutagenesis experiments.
Determination of mitochondrial membrane potential. To determine the mitochondrial membrane potential of U 0 A L cells, a membrane potentialsensitive fluorescent probe JC-1 (Molecular Probes) was used (35) . JC-1 is a cationic carbocyanine dye that presents itself as green fluorescent monomers at low concentration (i.e., in cells with low mitochondrial function or membrane potential). In contrast, in cells with normal mitochondrial function, membrane potential-driven accumulation of these dyes resulted in the formation of yellowish-red fluorescent J-aggregates. Briefly, control and U 0 cells were plated into 35 mm glass bottom microwell dishes as described above. After overnight incubation, the cells were loaded with 10 Amol/L JC-1 for 30 minutes at 37jC, washed and viewed using a epifluorescence confocal microscope with either a green excitation filter at 488 nm or a blue excitation filter at 543 nm, which allows the visualization of the green and red fluorescence, respectively, on a heated 37jC stage.
Western blotting of 3-nitrotyrosine-containing protein. Control and arsenite-treated cells were harvested and proteins extracted as described (36) . The samples were then centrifuged and the protein content of the supernatant was determined by Bradford assay (37) . Thirty micrograms of total cell lysate from each treatment group was fractionated by SDS-PAGE gel, transferred onto Hybond membranes, and immunoblotted with rabbit antinitrotyrosine antibody (0.5 Ag/mL, Upstate Biotechnologies, Lake Placid, NY) at 4jC. Peroxidase-conjugated anti-rabbit IgG (1:10,000, The Jackson Laboratory, Bar Harbor, ME) was used to detect 3-nitrotyrosinecontaining proteins by the enhanced chemiluminescence (ECL) procedure (Amersham, Arlington Heights, IL). Cells treated overnight with peroxynitrite (80 Amol/L, Upstate Biotechnologies) were used as positive controls.
Mutation assay. After treatment of either whole cells or cytoplasts with arsenite, followed by rescue fusion with karyoplasts to reconstitute A L cells in the latter case, cultures were replated into T25 flasks and cultured for 5 to 7 days. This expression period is needed to permit surviving cells to recover from the temporary growth lag caused by arsenite and loss of expression of CD59 surface antigen in mutant cells. To determine mutant fractions, 5 Â 10 4 cells were plated into each of six 60 mm dishes as described (11, 13, 27) . The mutant fraction at each dose (M F ) was calculated as the number of surviving colonies divided by the total number of cells plated after correction for any nonspecific killing due to complement alone.
Statistical analysis. Data were presented as mean and standard derivations. Comparisons of fluorescent intensity and mutant fractions between treated groups and controls were made by Student's t test. P V 0.05 between groups was considered to be significant. 
Results
Induction of reactive oxygen species by arsenite in cytoplasts. To ascertain if the nucleus is a necessary target for arseniteinduced genotoxicity in mammalian cells, enucleated cytoplasts were exposed to arsenite followed by rescue fusion with normal karyoplasts from untreated cells to determine whether gene mutations can be induced in the absence of direct nuclear damage by arsenite. First, we determined if cytoplasts, upon arsenic treatment, could generate reactive oxygen species. Figure 1 shows representative confocal images of fluorescent signals from control (A-C) and enucleated A L cells (D-F) pretreated with the fluorescent probe, CM-H 2 DCFDA, for 40 minutes and subsequently treated with sodium arsenite (2 Ag/mL) for 5 minutes before the pictures were taken. The nonfluorescent dye passively diffuses into cells where the acetates are cleaved by intracellular esterase (32, 38) . The resulting diol is more polar and is better retained inside the plasma membrane. The diol can then be oxidized by oxyradical species to the fluorescent form with absorbency at 504 nm. The fluorescent signals obtained were quantified as a surrogate index for the production of reactive oxygen species using Adobe Photoshop image analysis software as described (13) . A 2 Ag/mL dose of arsenite (15.4 Amol/L) increased the average fluorescent intensity in whole cells by 2.5-fold above control levels (Fig. 1B versus A) . Likewise, enucleated cells treated with sodium arsenite (Fig. 1E) were able to generate radical species in the absence of nuclei. Similar to the whole cells, cytoplasts treated with arsenite had an average fluorescent intensity 2.4-fold above nontreated counterparts (Fig. 1E versus D) . Arsenite-treated cytoplasts showed a fluorescent intensity f77% that of comparatively treated whole cells (55.7 F 3.8 versus 72.3 F 7.1; Fig. 1E versus B) . In the presence of 0.1% DMSO, a radical quencher, the fluorescent signals in both arsenite-treated control culture (Fig. 1C ) and enucleated cells (Fig. 1F) were reduced to essentially background levels, thus confirming the oxyradical nature of the fluorescent signals.
Mutagenicity of arsenite-treated cytoplasts. To determine if cytoplasts can initiate signaling pathways resulting in genotoxic damage upon arsenite treatment, enucleated cells were treated with arsenite (2 Ag/mL for 3 hours) and immediately fused with karyoplasts at a ratio of 3:1. This relatively short treatment period was necessary because the viability of cytoplasts decreased rapidly after 4 to 5 hours postenucleation (data not shown; ref. 39) . When cytoplasts were fused with karyoplasts under the conditions used in the present study, three fusion outcomes were possible. First, a karyoplast could fuse with another karyoplast to produce an unstable doublet. A second possible outcome was that a cytoplast fused with another cytoplast to produce another nonviable cytoplasmic doublet. The only viable outcome would be the fusion of a cytoplast with a karyoplast. Whereas the fusion efficiency was only 15% to 20%, the successfully fused cells had a high viability index (f80%) as determined by colony-forming capacity. Cultures formed by fusion of nontreated cytoplasts with nuclei in a similar manner were used as controls. As shown in Fig. 2 , treatment of cytoplasts alone with arsenite resulted in a total mutant fraction of 297 F 29 CD59
À mutants per 10 5 survivors. Given the background mutation incidence from the fusion of nontreated cytoplasts to nuclei was 124 F 17, the induced mutant fraction due to arsenite-induced cytoplasmic damage was 173 F 23 CD59 À mutants per 10 5 survivors. Inactivation of mitochondrial membrane potential in R 0 cells. Our next approach was to ascertain the contribution of mitochondria in mediating the genotoxic response of A L cells to arsenite treatment. First, we determined if U 0 A L cells have normal mitochondrial membrane potential. U 0 A L cells were generated by long-term treatment with the DNA-intercalating agent ditercalinium in the presence of uridine. The degree of mtDNA depletion depends on the treatment period. After treatment for 3 to 4 months, several clonal isolates were completely depleted of their endogenous mtDNA, as determined by PCR assay (Fig. 3A) . Mitochondrial function in control and U 0 A L was determined using JC-1 stain as shown in Fig. 3B and C. In cells with normal mitochondrial function, membrane potential-driven accumulation of these dyes results in the formation of red fluorescent J-aggregates as shown in control A L (Fig. 3B ) . In UjA L cells with depressed mitochondrial membrane potential, the mitochondria seem green when stained with JC-1 dye for a comparable period of 30 minutes at 37jC (40) to reduce the preexisting mutant fraction similarly showed no mutant induction upon treatment with arsenic (data not shown). These data strongly suggest that mitochondria function is necessary for arsenic-induced genotoxicity.
Role of peroxynitrites in arsenic-induced genotoxicity. 5) . The suppression by L-NMMA on arsenic-induced mutant fraction at either doses was highly significant (P < 0.05). In contrast, the inactive enantiomer, D-NMMA, was totally inactive in suppressing the mutagenicity of arsenic (column 6 versus 4). Treatment with L-NMMA alone was neither toxic nor mutagenic to A L cells (column 7). Arsenite induces 3-nitrotyrosine protein modification in A L cells. Because peroxynitrite promotes nitration and oxidation of phenolic compounds, such as tyrosine, formation of 3-nitrotyrosine-containing proteins has often been used as a biomarker of peroxynitrite induction in mammalian cells (41, 42) . Figure 6 shows the dose response induction of 3-nitrotyrosine modification of a 110 kDa protein band in arsenite-treated (24 hours) A L cells. Peroxynitrite (80 Amol/L overnight treatment) was used as positive control in the Western blot. Addition of L-NMMA (1 mmol/L) to the arsenite-treated group (1 Ag/mL) reduced the level of protein modification to essentially control level and attested to the peroxynitrite origin of the reaction.
Discussion
The metalloid arsenic, while a natural component of the earth's crust, is a serious environmental concern and a global health problem affecting millions of people. A better understanding of the mutagenic/carcinogenic mechanism of arsenic should provide a basis for better interventional approach in both treatment and prevention.
Using the highly sensitive human-hamster hybrid (A L ) cell assay that is proficient in recovering multilocus deletions, we dispelled the earlier notion that arsenic is a nongenotoxic carcinogen (11) (12) (13) . Using ESR spin trap, we further showed that superoxide-driven hydroxyl radicals are an important mediator in the genotoxicity of arsenic (13) . The obvious questions that follow are ''What is the origin of these reactive oxygen species?'' and ''Can there be any other secondary radical species involved in the process?'' Using enucleation and cell fusion techniques, we show here that mitochondria are an important target of arsenic-induced genotoxicity. The generation of superoxide anions is consistent with the downstream induction of peroxynitrites, the effect of which can be reduced by an inhibitor of nitric oxide synthase (43) . Thus, the genotoxicity of arsenic is mediated by a combination of both reactive oxygen and nitrogen species.
An important corollary of the present study is that the nucleus is not necessarily the only and sufficient target for environmental carcinogens. Treatment of cytoplasts with arsenic, in the absence of the nucleus, initiates oxyradical production, as detected by using CM-H 2 DCFDA. This induction, however, is only f77% of the level measured in whole cells and is likely to be a result of the loss of a small amount of cytoplasm during the enucleation process, either as free vesicles or as ruminants attached to the karyoplasts. These data suggest that cytoplasm plays an essential role in the initiation of oxidative damage, an observation previously made with targeted cytoplasmic irradiation by a particles (44) .
Mitochondria, being the metabolic center of a cell, are intimately involved in the production of reactive oxygen species, mainly superoxides and hydrogen peroxides. Approximately 2% to 4% of the oxygen consumed by mitochondria is converted to superoxides by the electron transport system (45) . Mitochondrial structures, on the other hand, are also very susceptible to oxidative damage through membrane lipid peroxidation, protein oxidation, and mtDNA damage. Evidence implicating mitochondria as a possible target of arsenic toxicity has been obtained mainly through the induction of apoptosis in various leukemia and cancer cell lines (46, 47) . Our findings that A L cells with diminished mitochondrial function are unable to respond to arsenic-induced genotoxic damage are corroborated with the observation that the antioxidant, N-acetylcysteine, completely suppressed arsenic-induced apoptosis in HeLa cells by preventing mitochondrial membrane depolarization (23) .
In the present study, the role of mitochondria in mutant induction by arsenic was evaluated by two complementary approaches: (a) with reconstituted cells made by the fusion of arsenic-treated cytoplasts with karyoplasts from controls to show that the nucleus need not be present at the time of arsenic treatment and (b) U 0 A L cells without mtDNA and diminished mitochondrial membrane potential responded poorly to arsenite-induced mutagenesis. Although treatment with ditercalinium toward the generation of Fig. 4; refs. 11-13 ). Although increases in intracellular oxidant levels can also be mediated by other cytosolic components including lysosomes, endoplasmic reticulum, and membrane-bound NADPH oxidase (48), our findings using U 0 A L cells clearly defined mitochondria as a primary target in mediating the DNA-damaging effect of arsenic in mammalian cells. In this regard, our current data are consistent with our previous observations that Rhodamine 6G-treated A L cells with diminished mitochondrial membrane potential show essentially no mutations upon exposure to arsenic. 5 Peroxynitrite anion is a strong oxidant and nitrating species resulting from the near diffusion-controlled reaction of superoxide with nitric oxide (49) . There is evidence that, in tissues, peroxynitrites not only escape the scavenging by most low molecule weight antioxidants (50) , but can also activate stress responsive pathways and kinases of the src family to modulate cellular signal transduction cascade (49, 51) . Because mitochondria constitute a primary locus for the intracellular formation and reactions of peroxynitrite, which has a much longer half life compared with hydroxyl radicals and can readily diffuse across biomembranes (43) , it is likely that multiple radical species are involved in the genotoxic response of arsenic. Our present findings are consistent with the observation that nitric oxide, an upstream molecule in the biosynthesis of peroxynitrite, has been implicated in endothelial cell damages associated with arsenic exposure (52) .
Although formation of 3-nitrotyrosine has been used as marker of endogenous peroxynitrite formation (41, 42) , there is recent indication that other reactions, such as myeloperoxidase with hydrogen peroxide, can also lead to nitrotyrosine formation (53) . As a result, an increase in 3-nitrotyrosine content, as detected by Western blot in the present study, should be viewed as an indicator of an increase in nitrosative damage, an interpretation that does not alter the conclusion of the present findings.
The CD59 locus of the A L cells used in this study has been used successfully in detecting mutagens that induce predominately large deletions, such as radiation (54) and asbestos fibers (55) , findings that have subsequently been confirmed using other mutagenic assay systems that are equally proficient in recovering multilocus deletions (56, 57) . There is no evidence that the A L cell is intrinsically hypermutable (25, 54, 58) and its mutability at the HPRT locus (located on the X-chromosome of the hamster gene) is no different from that of other human or rodent cell lines (11, 25, 55) . Whereas the A L cell assay is a useful model for mechanistic studies, precise carcinogenic mechanism for arsenic in specific target tissues, such as the skin and lung, where compounding factors may be present, need to be further evaluated.
Although epidemiologic studies have firmly established that arsenic is a human carcinogen, the mechanism whereby arsenic induces human cancer remains unclear and is likely to involve more than one mechanism (see refs. 59, 60 for review). The doses of arsenite used in the present study (1-2 Ag/mL or 1-2 ppm) are very high compared with the arsenic level generally found in drinking water supplies in the United States, with the exception of some Southwest states where arsenic in the level of 200 to 300 ppb and, in few cases, >1 ppm, have been identified (1, 61) . However, in certain parts of Bangladesh and West Bengal in India, as many as 5% of the drinking wells that were sampled had arsenic level exceeding 1 ppm and that 17% of the wells had levels exceeding 200 Ag/L (4, 62), 20 times higher than the current U.S. maximum contaminant level of 10 Ag/L. Thus, the dose used in the present study, while high according to the U.S. standard, is still environmentally relevant in other parts of the world. Furthermore, the treatment period used in the present study is only a matter of hours compared with chronic exposure in epidemiologic studies. There is evidence that arsenic may function as a cocarcinogen with UV light in the induction of skin cancers (63) . However, arsenic has been shown to induce chromosomal aberrations and sister chromatid exchanges in the lymphocytes of individuals living in highly contaminated areas (64) . Our present findings that mitochondria is an important target for arsenic-induced genotoxicity provide an additional impetus in focusing on mitochondria as an important cellular target in interventional remedy for arsenic-induced diseases. Figure 6 . Representative Western blot of 3-nitrotyrosine-modified protein, a marker of peroxynitrite anion formation, from either control or arsenite-treated (24 hours exposure) A L cells. Peroxynitrite-treated cells (80 Amol/L) were used as a positive control and h-actin was used as housekeeping control. Image was quantified using a densitometer and normalized to the h-actin level. Proteins containing 3-nitrotyrosine were detected using a polyclonal 3-nitrotyrosine antibody. A protein band with a size of 110 kDa was consistently identified. Treatment with L-NMMA reduced the level of protein modification in arsenite-treated cells (1 Ag/mL) to essentially control levels.
